Oncology Institute Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | +10.4% | +209.7% | +28.6% | -20.0% | -17.5% | -4.7% | |
| – | – | +36.4% | +418.4% | -15.3% | +10.0% | -21.7% | +0.3% | |
| – | – | +145.2% | +1,805.6% | -87.7% | +139.0% | +48.3% | -32.4% | |
| – | – | +145.2% | +1,805.6% | -35.4% | +12.3% | -40.1% | -32.4% | |
| – | – | +17.1% | +23.1% | +90.3% | +6.1% | +13.4% | +21.9% | |
| – | – | +12.0% | +47.9% | +43.8% | +47.7% | -26.6% | +68.1% | |
| – | – | +35.7% | +99.2% | +103.9% | – | – | – | |
| – | – | +1.1% | +87.2% | -19.6% | -66.2% | +0.0% | +0.0% | |
| – | – | -11.3% | -6.5% | -1.6% | -0.3% | -17.3% | -25.6% | |
| – | – | +117.3% | +164.1% | +39.5% | +9.9% | +11.1% | +6.7% | |
| – | – | +110.6% | +4.2% | -0.3% | +17.1% | +50.1% | +35.9% | |
| – | – | – | -96.6% | +2,904.4% | +15.7% | +6.8% | +5.3% | |
| – | – | +42.3% | +23.1% | -39.8% | +54.0% | +68.6% | +77.5% | |
| – | – | – | – | – | +7.7% | +7.3% | -16.9% | |
| – | – | -33.4% | +270.7% | +18.3% | -53.7% | -93.7% | -538.0% | |
| – | – | – | – | – | – | – | – | |
| – | +0.0% | -8.3% | +12.0% | +21.7% | -8.5% | +1.8% | +1,131.1% |
Data as of: August 11, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.